Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
114-hr-3618114th Congress
Orphan Drug Fairness Act
Sponsored By: Representative Lance, Leonard [R-NJ-7]
Unknown
Summary
Orphan Drug Fairness Act This bill amends the Patient Protection and Affordable Care Act (PPACA) to exclude sales of any drug or biological product approved by the Food and Drug Administration solely for rare diseases or conditions (orphan drug) from the calculation of the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million. This Act is effective as if included in PPACA.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Lance, Leonard [R-NJ-7]
NJ • R
Cosponsors
Rep. Pascrell, Bill, Jr. [D-NJ-9]
NJ • D
Sponsored 9/25/2015
Rep. Sánchez, Linda T. [D-CA-38]
CA • D
Sponsored 9/25/2015
PATRICK TIBERI
OH • R
Sponsored 9/25/2015
Rep. Holding, George [R-NC-2]
NC • R
Sponsored 9/25/2015
Rep. Black, Diane [R-TN-6]
TN • R
Sponsored 10/1/2015
Rep. Nunes, Devin [R-CA-22]
CA • R
Sponsored 10/20/2015
Rep. Marchant, Kenny [R-TX-24]
TX • R
Sponsored 10/21/2015
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov